Royalty Pharma plc (RPRXN)
BMV
1,049.21
+43.44 (+4.32%)
Real-time Data
02:30 PM
Day's Range
1,049.211,049.21
52 wk Range
665.901,049.21
Financial Statements - RPRXN - Royalty Pharma plc
Revenue
2.37B
Net Income
1.32BNet Margin 55.7%
EBITDA
1.61B
Free Cash Flow
2.48B
Income Statement
| Period Ending | 2025-12-31 |
|---|---|
| Sales | 2.37B |
| Cost of Goods | - |
| Gross Profit | - |
 Operating Expense | - |
| Operating Income | 1.55B |
| Non-Operating Interest | - |
| Other Income Expense | 38.74M |
| Pre Tax Income | 1.32B |
| Income Tax | 0 |
| Net Income | 1.32B |
| EPS Basic | 1.79 |
| EPS Diluted | 1.78 |
| Basic Shares Outstanding | 429.80M |
| Diluted Shares Outstanding | 429.80M |
| Ebit | 1.63B |
| Ebitda | 1.61B |
| Net Income Continuous Operations | 1.32B |
| Minority Interests | -553.24M |
| Preferred Stock Dividends | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
